Fintech PR
CSCI attends the 2020 Hong Kong Fintech Week, unveiling its bond credit rating and trading services tailored made for offshore bond market
China Securities Credit Investment Co., Ltd. (hereinafter referred to as”China Securities Credit Investment”), a national comprehensive credit service organization, together with its subsidiaries that focus on overseas strategy and business development – China Securities Credit Investment Technology Co., Ltd. (hereinafter referred to as “China Securities Credit Technology”) and Pengyuan Credit Rating (Hong Kong) Co., Ltd. (hereinafter referred to as “Pengyuan International”) made its debut again at the global renown fintech event -2020 Hong Kong Fintech Week, presenting online fintech studio regarding overseas funds entry into Chinese bond markets. A series of innovative solutions such as DMI bond quotation and information services from China Securities Credit Technology and credit rating services from Pengyuan International were also released.
Committed to providing full credit value chain services driven by technology
In 2018, China Securities Credit Investment (CSCI) made its debut at the Hong Kong Fintech Week and aroused strong responses. This year marked the fifth anniversary of Hong Kong Fintech Week with a brand new online conference mode and CSCI was invited to participate again.
As the leading Chinese integrated credit-tech service provider, CSCI aims to build an infrastructure that serves the entire life cycle of credit assets (asset generation – asset trading and exchange – asset management) empowered by its technology. It provides integrated services that cover the entire credit value chain, from credit risk management, credit enhancement, to credit asset trading services and management. In response to the low market recognition and insufficient liquidity of RMB assets in overseas markets due to opaque information, CSCI aims to provide overseas markets with high-quality and valuable international credit ratings, data and information services through the Hong Kong business platform, in order to help foreign investors understand RMB assets more comprehensively, objectively and quickly as well as increase their recognition and participation in RMB assets.
As the world economy has entered the era of low interest rates, the income of Chinese assets has obvious advantages on a global scale. The Chinese government has opened up for foreign capital markets in order to bring more money flowing in and out of the country. However, data shows that foreign capital still has concerns about entry the Chinese financial market especially the bond market. The online fintech studio on “Is Wall Street Ready to Accept Chinese Assets?” organized by CSCI and its subsidiaries aims to analyze the current situation of foreign capital entry the Chinese credit market and explore future opportunities. This panel connected distinguished guests from Shanghai, Hong Kong and Beijing, including Yang Yang, CEO of China Securities Credit Technology; Terry Zhang, Head of Global Strategy and Business Management of Pengyuan International; and Zhai Chenxi, Chairman of the Board of TF International Securities Group, Co-President of HengTai Securities and attracted approximately 25,000 attendees around the world.
Huge opportunities behind China’s credit bond market
“China is one of the world’s largest bond markets with the second largest scale globally. At present, international investors only account for about 10% of our local interest bond market. It is expected that the proportion of international investors in China’s bond local currency market will increase to 20% in the near future,” Zhai Chenxi from TF International put it.
When it comes to the differences between China’s bond transactions and overseas’, Yang Yang from China Securities Credit Technology (CSCT) admitted that due to the lack of information about Chinese bonds on the overseas market platforms, foreign institutions do not know which direction to focus on when investing in Chinese bonds. In response to it, Yang Yang introduced the current status of the domestic credit bond market and the main trading methods, and stated,”In China, about 90% of Chinese bond issuers have not made their debut in the international market. Therefore, despite the great opportunities behind China’s credit bond market, foreign investors are not familiar with them.”
As a market innovator, CSCT has built a comprehensive bond information platform for global financial institutions. The DMI terminal (www.cscidmi.com) launched by CSCT made great efforts to eliminate the information asymmetry of the two markets. It determines to build a Chinese bond quotation and information platform for overseas investment institutions, and provide foreign investors with various analytical tools and first-hand news information. It helps them better understand the Chinese market, effectively reduce credit risk, and use technology to empower China’s credit bond market. This will be the gateway for foreign investors into the Chinese market.
Huge data value in China’s domestic ratings
Regarding the doubts of global investors about whether China’s domestic credit ratings are inflated, Terry Zhang from Pengyuan International stated that China’s domestic ratings are in parallel with global credit ratings and cannot be directly compared. The global investors must realize a few things, firstly these domestic ratings are just of a different scale than the one they used to; seccondly, the domestic rating does carry great data value although it has much room to improve, and lastly, they should never confuse domestic rating to the global ones when they make investment decision.
As an international credit rating agency, Pengyuan International understands the differences between global and domestic credit ratings and is committed to providing reliable rating services for the global capital market. It uses data to enable international investors to better understand market trends through rating agencies. In addition to the distribution of global ratings authorized by the issuer, Pengyuan International can also conduct ratings based on the needs of global investors, according to the global scale, and combined with local conditions, which can well support and improve the decision-making of global investors.
Chen Hao, Chief Data Officer of CSCI put it, “We are honored to participate in Hong Kong Fintech Week again. As China’s leading credit technology company, China Securities Credit Investment Group will rely on highly effective technology innovation and keen sense of the market demand, forge ahead and become a highly influential technology service provider in China’s offshore bond market.”
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News4 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News5 days ago
Silent Eight secures AIA as its latest client
-
Latest News3 days ago
CGTN: China, Germany eye more resilience and vitality in bilateral ties